Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alterity Therapeutics ( (AU:ATH) ) has issued an update.
Alterity Therapeutics Limited has announced its Annual General Meeting scheduled for November 21, 2025, at Deloitte Australia’s offices in Melbourne. The company emphasizes the importance of shareholders submitting proxy forms and questions in advance to facilitate a well-prepared meeting. This announcement highlights Alterity’s commitment to transparent communication with its stakeholders and adherence to new provisions under the Corporations Act.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic products for neurodegenerative diseases. The company is dedicated to advancing treatments that target the underlying causes of these conditions, with a market focus on innovative healthcare solutions.
YTD Price Performance: 20.0%
Average Trading Volume: 14,320,608
Technical Sentiment Signal: Sell
Current Market Cap: A$130.5M
For an in-depth examination of ATH stock, go to TipRanks’ Overview page.